| HOME >> BIOLOGY >> TECHNOLOGY |
Zieses joins the Double Helix Consulting US team from the Pricing & Reimbursement consulting practice of IMS Health. She has worked closely with both large and small pharmaceutical and biotech clients to deliver global strategic recommendations that would inform decisions related to drug pricing, market access, clinical trial design, value messaging, payer attitudes, forecasting, and commercial assessments. Her expertise in US payer trends spans both public and private organizations and the policy changes they continually face. She has extensive experience in a diverse set of therapy areas, in particular those related to neurosciences, pulmonology, immunology and ophthalmology. She also has four years of previous client services experience in the Equity Research division of Lehman Brothers. Caryn holds an MBA from the Kellogg School of Management, an MEM from Northwestern University, and a BSE in Chemical Engineering from the University of Pennsylvania.
http://www.doublehelixdevelopment.com
(Photo: http://www.newscom.com/cgi-bin/prnh/20090720/NY49139 )
(Logo: http://www.newscom.com/cgi-bin/prnh/20090330/NY91277LOGO'/>"/>
| SOURCE Double Helix Consulting US Copyright©2009 PR Newswire. All rights reserved |